SGRYSurgery Partners, Inc.
- GlobeNewswire
Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance
BRENTWOOD, Tenn., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today ...
- GlobeNewswire
Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction
BRENTWOOD, Tenn., July 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today ...
- GlobeNewswire
Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance
BRENTWOOD, Tenn., May 05, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the ...
- GlobeNewswire
Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., April 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the ...
- PR Newswire
SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES
Surgery Partners (NASDAQ: SGRY) investors lost money after the Company's Q4 2025 earnings revealed a significant gap between the adjusted figures... ...
- GlobeNewswire
SGRY GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- LEVI & KORSINSKY, LLP INVESTIGATES
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Surgery Partners (NASDAQ:SGRY) shareholders watched the stock drop sharply in early March 2026 after Q4 2025 results and FY 2026 outlook both fell short of expectations. ...
- PR Newswire
SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES
Surgery Partners (NASDAQ: SGRY) investors lost money after the Company's Q4 2025 earnings revealed a significant gap between the adjusted figures... ...
- PR Newswire
SGRY GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- LEVI & KORSINSKY, LLP INVESTIGATES
Surgery Partners (NASDAQ: SGRY) shareholders watched the stock drop sharply in early March 2026 after Q4 2025 results and FY 2026 outlook both fell... ...
- GlobeNewswire
Surgery Partners, Inc. Names Lloyd Dean to Board of Directors
BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") recently announced that Lloyd Dean has been appointed to serve as an independent director ...
- GlobeNewswire
Surgery Partners (SGRY) Guided for Margin Expansion While Headwinds Mounted -- Levi & Korsinsky, LLP Investigates
NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners (NASDAQ:SGRY) shareholders watched the stock drop sharply in early March 2026 after Q4 2025 results and FY 2026 outlook both fell short of expectations. ...
- PR Newswire
SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES
Surgery Partners (NASDAQ: SGRY) investors lost money after the Company's Q4 2025 earnings revealed a significant gap between the adjusted figures... ...
- BusinessWire
Ortelius Delivers Open Letter to Surgery Partners Stockholders
Surgery Board and Management Team Have Presided Over the Vast Destruction of Value and Must Be Held Accountable Letter Outlines Multiple Paths to Building and Unlocking Intrinsic Value for Stockholders Divestiture ...
- GlobeNewswire
Surgery Partners, Inc. to Present at Upcoming Investor Conference
BRENTWOOD, Tenn., March 09, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), is scheduled to meet with investors at the Barclays 28th Annual Global ...
- Analyst Upgrades
TD Cowen Maintains Buy on Surgery Partners, Lowers Price Target to $20
TD Cowen analyst Ryan Langston maintains Surgery Partners with a Buy and lowers the price target from $28 to $20. ...
- Analyst Upgrades
UBS Maintains Buy on Surgery Partners, Lowers Price Target to $21
UBS analyst A.J. Rice maintains Surgery Partners with a Buy and lowers the price target from $29 to $21. ...
- Analyst Upgrades
Mizuho Maintains Outperform on Surgery Partners, Lowers Price Target to $17
Mizuho analyst Ann Hynes maintains Surgery Partners with a Outperform and lowers the price target from $19 to $17. ...
- PR Newswire
ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS
Ziegler, a specialty investment bank, is pleased to announce that it served as the exclusive financial advisor to Preferred Vascular Group (PVG) in... ...
- Analyst Upgrades
RBC Capital Maintains Outperform on Surgery Partners, Lowers Price Target to $20
RBC Capital analyst Ben Hendrix maintains Surgery Partners with a Outperform and lowers the price target from $31 to $20. ...
- Analyst Upgrades
Barclays Maintains Equal-Weight on Surgery Partners, Lowers Price Target to $14
Barclays analyst Andrew Mok maintains Surgery Partners with a Equal-Weight and lowers the price target from $18 to $14. ...
- GlobeNewswire
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2025 Results; Sets 2026 Guidance; Announces Share Repurchase Program
BRENTWOOD, Tenn., March 02, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for ...
- GlobeNewswire
Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the ...
- Analyst Upgrades
Mizuho Maintains Outperform on Surgery Partners, Lowers Price Target to $19
Mizuho analyst Ann Hynes maintains Surgery Partners with a Outperform and lowers the price target from $22 to $19. ...
- GlobeNewswire
Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the ...
- PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY
Pomerantz LLP is investigating claims on behalf of investors of Surgery Partners, Inc. ("Surgery Partners" or the "Company") (NASDAQ: SGRY). Such... ...
- GlobeNewswire
Surgery Partners, Inc. Announces Add-On Senior Notes Offering
BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced today that Surgery ...